Cetera Advisors’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$30.6K Buy
25,500
+12,000
+89% +$12K ﹤0.01% 2380
2023
Q4
$20.4K Sell
13,500
-207
-2% -$299 ﹤0.01% 1773
2023
Q3
$21.9K Sell
13,707
-2,000
-13% -$3.64K ﹤0.01% 1681
2023
Q2
$34.1K Sell
15,707
-4,793
-23% -$7.5K ﹤0.01% 1619
2023
Q1
$29.9K Buy
20,500
+5,900
+40% +$7.59K ﹤0.01% 1612
2022
Q4
$18.3K Hold
14,600
﹤0.01% 1577
2022
Q3
$28K Sell
14,600
-3,000
-17% -$7.09K ﹤0.01% 1244
2022
Q2
$45K Buy
17,600
+2,500
+17% +$7.29K ﹤0.01% 1331
2022
Q1
$52K Sell
15,100
-5,000
-25% -$17.7K ﹤0.01% 1372
2021
Q4
$97K Buy
+20,100
New +$81.3K ﹤0.01% 1384

Other funds holding OPK

Cetera Advisors's OPK Position: Q1 2024 in Review

Cetera Advisors increased its Opko Health (OPK) stake by 89% in Q1 2024, buying an estimated $12K and bringing the position to 25,500 shares worth $30.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2380.

Cetera Advisors first reported a position in OPK in Q4 2021 and has held it in 10 quarters since. The position peaked at $97K in Q4 2021. 226 funds tracked by Wall St. Rank hold OPK as of Q1 2024.

  • Cetera Advisors held 25,500 shares of Opko Health worth $30.6K as of Q1 2024.
  • Cetera Advisors bought 12,000 Opko Health shares in Q1 2024, an estimated $12K.
  • Opko Health made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #2380 holding.
  • Cetera Advisors first reported a position in Opko Health in Q4 2021 and has held it in 10 quarters since.
  • Cetera Advisors's Opko Health position peaked at $97K in Q4 2021.
  • 226 funds tracked by Wall St. Rank held Opko Health as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.